Sprint Precision Technologies
688605
Jiangsu Jingxue Insulation Technology
301010
Global Infotech
300465
Hydsoft Technology
301316
Shanghai Fortune Techgroup
300493
CN Stock MarketDetailed Quotes
603858 Shandong Buchang Pharmaceuticals
- 17.22
- +0.14+0.82%
Noon Break Dec 12 11:29 CST
19.05BMarket Cap-64.98P/E (TTM)
17.27High16.96Low47.57KlotVolume17.08Open17.08Pre Close81.57MTurnover0.43%Turnover Ratio59.79P/E (Static)1.11BShares19.7052wk High1.71P/B19.05BFloat Cap14.0352wk Low18.79Limit Up1.11BShs Float86.04Historical High15.37Limit Down1.82%Amplitude13.36Historical Low0.13Dividend TTM17.15Avg Price22.18KlotAsk0.73%Div YieldTTM100Lot Size24.68KlotBid
Shandong Buchang Pharmaceuticals Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -14.71%8.51B | -21.93%5.43B | -24.88%2.64B | -11.41%13.25B | -11.69%9.98B | -1.98%6.96B | 9.83%3.51B | -5.15%14.95B | -0.64%11.3B | -3.90%7.1B |
| Operating revenue | -14.71%8.51B | -21.93%5.43B | -24.88%2.64B | -11.41%13.25B | -11.69%9.98B | -1.98%6.96B | 9.83%3.51B | -5.15%14.95B | -0.64%11.3B | -3.90%7.1B |
| Other operating revenue | ---- | -1.48%7.24M | ---- | 72.81%16.62M | ---- | 82.88%7.35M | ---- | --9.62M | ---- | 7.32%4.02M |
| Total operating cost | -12.17%7.98B | -19.36%5.06B | -20.38%2.47B | -7.73%12.23B | -9.34%9.08B | -1.13%6.28B | 7.93%3.11B | -6.34%13.25B | 0.67%10.02B | -1.31%6.35B |
| Operating cost | 16.68%3.65B | 7.18%2.34B | 2.79%1.09B | -0.34%4.22B | -7.86%3.13B | -5.40%2.18B | 20.35%1.06B | 2.41%4.23B | 14.25%3.4B | 18.53%2.3B |
| Operating tax surcharges | -23.97%122.82M | -34.04%73.79M | -28.87%40.71M | -7.20%215.36M | -4.29%161.54M | 3.03%111.86M | 10.62%57.24M | 2.28%232.07M | 4.38%168.78M | 2.42%108.57M |
| Operating expense | -32.42%3.27B | -38.78%2.07B | -37.91%1.06B | -14.90%6.37B | -11.64%4.84B | 1.44%3.38B | 4.52%1.71B | -9.83%7.48B | -5.39%5.48B | -10.51%3.33B |
| Administration expense | -9.98%664.11M | -14.47%405.88M | -8.57%204.65M | 10.36%995.94M | 13.28%737.73M | 6.65%474.56M | -1.84%223.84M | -3.67%902.46M | -2.53%651.25M | 3.24%444.98M |
| Financial expense | 38.82%89.98M | 63.23%59.38M | 85.01%27.75M | -19.26%91.66M | -29.10%64.81M | -44.31%36.38M | -53.77%15M | -19.30%113.53M | -9.80%91.42M | 3.34%65.32M |
| -Interest expense (Financial expense) | 11.67%94.77M | 19.05%62.56M | 11.72%29.35M | -18.63%109.93M | -19.69%84.87M | -27.87%52.55M | -38.24%26.27M | -19.24%135.1M | -4.91%105.67M | -8.61%72.85M |
| -Interest Income (Financial expense) | 74.83%-5.56M | 79.47%-3.58M | 84.84%-1.84M | 5.28%-18.82M | -45.88%-22.11M | -108.56%-17.45M | -48.06%-12.15M | 16.24%-19.87M | 13.67%-15.15M | 51.86%-8.37M |
| Research and development | 19.33%180.2M | 21.66%122.03M | 24.93%46.02M | 17.94%335.08M | -35.93%151.01M | 0.75%100.3M | -20.03%36.84M | -30.47%284.12M | -9.57%235.71M | -41.79%99.55M |
| Credit Impairment Loss | 33.09%17.92M | 276.54%28.18M | 4,902.47%25.95M | -1.11%-17.32M | 767.64%13.46M | 49.19%7.48M | -95.17%518.84K | 31.02%-17.13M | 47.96%-2.02M | 595.76%5.02M |
| Asset Impairment Loss | -1,511.27%-28.06M | -135.70%-22.29M | -109.95%-127.87K | 76.91%-700.72M | -136.23%-1.74M | -296.76%-9.46M | -72.45%1.29M | -2,089.12%-3.04B | 1,032.81%4.81M | 3,066.60%4.81M |
| Other net revenue | -73.15%59.44M | -78.73%42.63M | -58.28%46.09M | 80.22%-583.94M | -16.34%221.38M | -19.71%200.42M | -47.06%110.47M | -73,138.12%-2.95B | 23.17%264.64M | 18.66%249.6M |
| Fair value change income | 33.80%-779.84K | -350.70%-2.95M | ---1.96M | ---2.36M | ---1.18M | --1.18M | ---- | ---- | ---- | ---- |
| Invest income | -58.14%7.47M | -83.36%3.22M | -131.51%-2.12M | 678.38%21.29M | 50.87%17.85M | 101.85%19.37M | 328.79%6.74M | -84.47%2.74M | -61.79%11.83M | -75.32%9.6M |
| -Including: Investment income associates | 49.35%6.34M | -38.40%5.03M | -170.90%-1.95M | 1,023.70%10.3M | 4.70%4.25M | 55.83%8.17M | 159.88%2.75M | -108.85%-1.12M | -85.91%4.06M | -86.51%5.24M |
| Asset deal income | -96.31%23.48K | 109.50%33.87K | 115.34%1.24K | 97.84%1.53M | 12,307.58%636.51K | 397.38%16.17K | 71.34%-8.06K | -53.93%773.1K | -100.31%-5.21K | -103.93%-5.44K |
| Other revenue | -67.32%62.87M | -79.96%36.43M | -76.12%24.34M | 17.14%113.63M | -23.07%192.35M | -21.01%181.82M | -48.05%101.94M | -53.42%97M | 34.67%250.02M | 35.04%230.19M |
| Operating profit | -46.91%594.91M | -53.32%409.58M | -58.91%213.13M | 134.90%436.02M | -27.66%1.12B | -11.83%877.39M | -2.27%518.68M | -177.10%-1.25B | -5.44%1.55B | -14.19%995.11M |
| Add:Non operating Income | 11.24%2.86M | 55.96%1.97M | -56.20%334.02K | 74.59%7.84M | 24.28%2.57M | 6.32%1.27M | -62.46%762.63K | 81.83%4.49M | 12.22%2.07M | -16.74%1.19M |
| Less:Non operating expense | 126.43%95.92M | -47.26%7.58M | -37.61%3.06M | 241.92%49.3M | 272.47%42.36M | 74.52%14.37M | -26.13%4.9M | -60.47%14.42M | -47.73%11.37M | -22.67%8.23M |
| Total profit | -53.57%501.85M | -53.26%403.97M | -59.11%210.4M | 131.33%394.56M | -29.81%1.08B | -12.53%864.29M | -2.20%514.54M | -179.38%-1.26B | -4.85%1.54B | -14.11%988.06M |
| Less:Income tax cost | 13.78%283.97M | 23.32%222.84M | 56.10%122.7M | -26.81%242.69M | -20.91%249.57M | -11.53%180.71M | -31.83%78.6M | -30.67%331.59M | -17.00%315.56M | -10.00%204.26M |
| Add:Adjusted items effecting net profit | ---- | ---- | ---- | ---- | ---- | --0.01 | ---- | ---- | ---- | ---- |
| Net profit | -73.79%217.88M | -73.50%181.14M | -79.88%87.7M | 109.55%151.87M | -32.10%831.23M | -12.79%683.58M | 6.12%435.94M | -243.55%-1.59B | -1.12%1.22B | -15.12%783.8M |
| Net profit from continuing operation | -73.79%217.88M | -73.50%181.14M | -79.88%87.7M | 109.55%151.87M | -32.10%831.23M | -12.79%683.58M | 6.12%435.94M | -243.55%-1.59B | -1.12%1.22B | -15.12%783.8M |
| Less:Minority Profit | -1.15%-94.99M | 19.62%-50.28M | -36.14%-26.32M | -172.88%-167.11M | -120.45%-93.91M | -80.95%-62.56M | -1.53%-19.33M | -13.75%-61.24M | -19.10%-42.6M | -52.81%-34.57M |
| Net profit of parent company owners | -66.18%312.86M | -68.98%231.42M | -74.96%114.02M | 120.85%318.97M | -26.97%925.14M | -8.83%746.14M | 5.91%455.27M | -231.63%-1.53B | -0.56%1.27B | -13.50%818.38M |
| Add:Adjusted items effecting net profit of parent company owners | ---- | ---- | ---- | ---- | ---- | --0.01 | ---- | ---- | ---- | ---- |
| Earning per share | ||||||||||
| Basic earning per share | -65.69%0.287 | -68.72%0.211 | -74.85%0.1035 | 120.85%0.2884 | -26.98%0.8364 | -8.83%0.6746 | 5.92%0.4116 | -231.64%-1.3831 | -0.56%1.1454 | -13.50%0.7399 |
| Diluted earning per share | -65.69%0.287 | -68.72%0.211 | -74.85%0.1035 | 120.85%0.2884 | -26.98%0.8364 | -8.83%0.6746 | 5.92%0.4116 | -231.64%-1.3831 | -0.56%1.1454 | -13.50%0.7399 |
| Other composite income | 87.18%-68.69K | 41.17%-349.03K | 91.25%-203.62K | 95.83%-298.75K | 94.21%-535.91K | 92.51%-593.32K | -19.97%-2.33M | -138.12%-7.16M | -153,921.13%-9.25M | -34,894.16%-7.92M |
| Other composite income of parent company owners | 87.18%-68.69K | 41.17%-349.03K | 91.25%-203.62K | 95.83%-298.75K | 94.21%-535.91K | 92.51%-593.32K | -19.97%-2.33M | -138.12%-7.16M | -153,921.13%-9.25M | -34,894.16%-7.92M |
| Add:Adjusted items effecting composite income | ---- | ---- | ---- | ---- | ---- | ---0.01 | ---- | ---- | ---- | ---- |
| Total composite income | -73.78%217.81M | -73.53%180.79M | -79.82%87.5M | 109.48%151.57M | -31.63%830.7M | -11.97%682.99M | 6.05%433.61M | -241.80%-1.6B | -1.87%1.22B | -15.98%775.88M |
| Total composite income of parent company owners | -66.17%312.79M | -69.01%231.07M | -74.87%113.81M | 120.73%318.67M | -26.48%924.61M | -8.01%745.54M | 5.85%452.94M | -230.15%-1.54B | -1.28%1.26B | -14.34%810.45M |
| Total composite income of minority owners | -1.15%-94.99M | 19.62%-50.28M | -36.14%-26.32M | -172.88%-167.11M | -120.45%-93.91M | -80.95%-62.56M | -1.53%-19.33M | -13.75%-61.24M | -19.10%-42.6M | -52.81%-34.57M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
